When are apparently non-clonal abnormalities in bone marrow chromosome studies actually clonal?

Area of Science:

• Cytogenetics
• Hematologic Neoplasms
• Molecular Diagnostics

Background:

• A single abnormal cell in cytogenetic analysis may suggest a sub-clonality.
• Laboratories often perform additional testing, such as fluorescence in situ hybridization (FISH), to investigate these findings.
• The clinical utility of extensive follow-up testing for every instance of a non-clonal abnormal cell is not well-defined.

Purpose of the Study:

• To evaluate the diagnostic yield of additional metaphase analysis when a non-clonal abnormal cell is detected in hematologic neoplasm studies.
• To identify specific criteria for when further cytogenetic investigation is beneficial.

Main Methods:

• Retrospective analysis of 500 cases with a non-clonal abnormal cell identified during a 20-cell count.
• Categorization of abnormal karyotypes into specific groups, including complex and recurring abnormalities.
• Assessment of the benefit of additional metaphase analysis based on karyotype characteristics.

Main Results:

• The benefit of additional metaphase analysis was found to be limited.
• Further analysis provided significant diagnostic value primarily in cases with complex karyotypes.
• Cases with classic, recurring abnormalities in hematologic neoplasms also benefited from additional analysis.
• The majority of other categories did not show a significant benefit from further investigation.

Conclusions:

• Additional metaphase analysis following the detection of a single abnormal cell is not universally beneficial.
• Targeted reflex testing for specific complex or recurring abnormal karyotypes can optimize diagnostic resources.
• This finding aids in refining laboratory protocols for investigating potential sub-clones in hematologic neoplasms.